Status:
RECRUITING
Efficacy of Oocyte Activation With Two Types of Ca2+ Ionophore.
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Conditions:
Infertility, Female
Eligibility:
FEMALE
Phase:
NA
Brief Summary
This study is a prospective ranzomized analysis including 372 human oocytes from 44 women. Half of the oocytes from the same patient will be randomly allocated to induce oocyte activation using two pr...
Detailed Description
Background: Oocyte non-activation (OAD) is the main cause of fertilization failure in intracytoplasmic sperm injection (ICSI) cycles. Oocyte activation involves a series of consecutive events that tak...
Eligibility Criteria
Inclusion
- Own oocyte patients who have had previous fertilization failure in previous cycles.
- Own oocyte patients with fertilization rate in previous cycles less than or equal to 30% of the microinjected oocytes.
Exclusion
- Oocyte Recipient Patients
- Sperm bank sperm recipient patients
- Patients who after oocyte decumulation have less than 2 mature oocytes.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06106412
Start Date
January 1 2024
End Date
December 1 2024
Last Update
March 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ivirma Valencia
Valencia, Spain, 46015